Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

NCT00490061 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Poor accrual.

Conditions

Head and Neck Cancer
Carcinoma, Squamous Cell
Head and Neck Cancers

Interventions

DRUG: Lapatinib
PROCEDURE: Radiotherapy (radiation)
DEVICE: G.E. Healthcare 1.5T MR, systems revision 12.0 M5
DEVICE: DCE-MRI

Sponsor

Quynh-Thu Le

Collaborators

[object Object]